Emeren downgraded to Market Perform from Outperform at Northland

Northland analyst Donovan Schafer downgraded Emeren to Market Perform from Outperform with a price target of $3.20, down from $6. The company reported a Q3 miss and weak Q4 guidance, the analyst tells investors in a research note. The firm is stepping aside until the company gets a few quarters under its belt with results that are more inline with guidance and expectations.